Skip to Content

What type of drug is Aliqopa?

Answers (1)

Official Answer by Drugs.com 10 Oct 2017

Aliqopa (copanlisib), from Bayer, is a phosphatidylinositol-3-kinase (PI3K) inhibitor (kinase inhibitor) indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least 2 prior treatments.

Follicular lymphoma is a slow-growing type of B-cell non-Hodgkin lymphoma, a cancer of the lymph system. Aliqopa works by blocking several enzymes that promote cancer cell growth.

See also: https://www.drugs.com/condition/follicular-lymphoma.html

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by Drugs.com

How many biosimilars have been approved in the United States?

Updated 8 Jan 2019 1 answerFAQ by Drugs.com

What are the brands of sumatriptan?

Updated 5 Feb 2019 1 answerFAQ by Drugs.com

What is botulinum toxin used to treat?

Updated 14 Feb 2019 1 answerFAQ by Drugs.com